1. NAME OF THE MEDICINAL
Granions MONEY 0.64 mg / 2 ml oral solution
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Silver nitrate ................................................................................................................1,060 mg
(Corresponding silver Quantity ............................................. ..................................... 0,640 mg)
To a 2 ml ampoule
Excipient with known effect: sodium
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Oral solution.
4. CLINICAL DATA
4.1. Indications
Used as a modifier of the land especially during viral infectious states of ENT, of flu symptoms and in case of mouth sores.
4.2. Dosage and method of administration
RESERVED FOR ADULTS.
2-3 ampoules per day: It is recommended to absorb the contents of the vials diluted in a glass of water without food.
4.3. Cons-indications
This drug is cons-indicated in patients who
Hypersensitivity to any component of the solution.
4.4. Special warnings and precautions for use
Treatment with this mineral trace element does not exempt of any specific treatment.
This medicine contains sodium. The sodium content is less than 1 mmol per dose, ie "sodium free".
4.5. Interaction with other medicinal products and other forms of interaction
The data available to date do not suggest the existence of clinically significant interactions.
4.6. Pregnancy and lactation
In the absence of experimental and clinical data and as a precaution, the use of this drug should be avoided during pregnancy and lactation.
4.7. Effects on ability to drive and use machines
Not applicable.
4.8. Adverse reactions
To date, no adverse effects were reported.
4.9. Overdose
No case of overdose has been reported.
However, use of doses higher than those recommended for a long time (chronic overdose) may result in argyria.
5. PHARMACOLOGICAL PROPERTIES
5.1. Pharmacodynamic properties
Pharmacotherapeutic group:
Oligotherapy
(V: miscellaneous)
Trace element mineral.
5.2. Pharmacokinetic properties
Unknown.
5.3. Preclinical safety data
Unknown.
6. PHARMACEUTICAL PARTICULARS
6.1. List of excipients
Amylose, glycerol, sodium sulfate, purified water.
6.2. Incompatibilities
Not applicable.
6.3. Retention period
3 years.
6.4. Special precautions for storage
Store at a temperature below 25 ° C.
6.5. Nature and contents of container
Dropping two points breakable brown glass type II 2ml. Boxes 10 and 30.
6.6. Special precautions for disposal and handling
No special requirements.
7. HOLDER OF MARKETING AUTHORISATION
LABORATORY Granions
7 rue industry
The Mercator
98000 MONACO
8. NUMBER (S) MARKETING AUTHORIZATION
304 619 0: 2 ml ampoule (brown glass), box of 10
3 394 388 or 34009 394 388 32: 2 ml ampoule (brown glass), 30 box.
9. DATE OF FIRST AUTHORIZATION / RENEWAL OF AUTHORIZATION
October 1 1997/1 October 2007
10. DATE OF REVISION OF THE TEXT
December 23, 2011.
11. DOSIMETRY
Not applicable.
12. INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS
Not applicable.
CONDITIONS OF PRESCRIPTION AND DELIVERY
Medicinal product not subject to medical prescription.
Réf. : 023620